Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Aβ immunotherapy

被引:10
作者
Das, Pritam [1 ]
Smithson, Lisa A. [1 ]
Price, Robert W. [1 ]
Holloway, Vallie M. [1 ]
Levites, Yona [1 ]
Chakrabarty, Paramita [1 ]
Golde, Todd E. [1 ]
机构
[1] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA
关键词
D O I
10.1186/1742-2094-3-17
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Microglial activation has been proposed to facilitate clearance of amyloid beta protein (A beta) from the brain following A beta immunotherapy in amyloid precursor protein (APP) transgenic mice. Interleukin-1 receptor 1 knockout (IL-1 R1-/-) mice are reported to exhibit blunted inflammatory responses to injury. To further define the role of IL-1-mediated inflammatory responses and microglial activation in this paradigm, we examined the efficacy of passive A beta immunotherapy in Tg2576 mice crossed into the IL-1 R1-/-background. In addition, we examined if loss of IL-1 R1-/-modifies A beta deposition in the absence of additional manipulations. Methods: We passively immunized Tg2576 mice crossed into the IL-1 R1-/-background (APP/IL-1 R1-/-mice) with an anti-A beta 1-16 mAb (mAb9, IgG2a) that we previously showed could attenuate A beta deposition in Tg2576 mice. We also examined whether the IL-1 R1 knockout background modifies A beta deposition in untreated mice. Biochemical and immunohistochemical A beta loads and microglial activation was assessed. Results: Passive immunization with anti-A beta mAb was effective in reducing plaque load in APP/IL-1 R1-/-mice when the immunization was started prior to significant plaque deposition. Similar to previous studies, immunization was not effective in older APP/IL-1 R1-/-mice or IL-1 R1 sufficient wild type Tg2576 mice. Our analysis of A beta deposition in the untreated APP/IL-1 R1-/-mice did not show differences on biochemical A beta loads during normal aging of these mice compared to IL-1 R1 sufficient wild type Tg2576 mice. Conclusion: We find no evidence that the lack of the IL-1 R1 receptor influences either A beta deposition or the efficacy of passive immunotherapy. Such results are consistent with other studies in Tg2576 mice that suggest microglial activation may not be required for efficacy in passive immunization approaches.
引用
收藏
页数:13
相关论文
共 59 条
[51]   Immunization with amyloid-β attenuates Alzheimer disease-like pathology in the PDAPP mouse [J].
Schenk, D ;
Barbour, R ;
Dunn, W ;
Gordon, G ;
Grajeda, H ;
Guido, T ;
Hu, K ;
Huang, JP ;
Johnson-Wood, K ;
Khan, K ;
Kholodenko, D ;
Lee, M ;
Liao, ZM ;
Lieberburg, I ;
Motter, R ;
Mutter, L ;
Soriano, F ;
Shopp, G ;
Vasquez, N ;
Vandevert, C ;
Walker, S ;
Wogulis, M ;
Yednock, T ;
Games, D ;
Seubert, P .
NATURE, 1999, 400 (6740) :173-177
[52]   Amyloid-β immunotherapy for Alzheimer's disease:: the end of the beginning [J].
Schenk, D .
NATURE REVIEWS NEUROSCIENCE, 2002, 3 (10) :824-828
[53]   MICROGLIAL INTERLEUKIN-1-ALPHA EXPRESSION IN BRAIN-REGIONS IN ALZHEIMERS-DISEASE - CORRELATION WITH NEURITIC PLAQUE DISTRIBUTION [J].
SHENG, JG ;
MRAK, RE ;
GRIFFIN, WST .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1995, 21 (04) :290-301
[54]  
Sheng JG, 1996, NEUROBIOL AGING, V17, P761
[55]   Intracranially administered anti-Aβ antibodies reduce β-amyloid deposition by mechanisms both independent of and associated with microglial activation [J].
Wilcock, DM ;
DiCarlo, G ;
Henderson, D ;
Jackson, J ;
Clarke, K ;
Ugen, KE ;
Gordon, MN ;
Morgan, D .
JOURNAL OF NEUROSCIENCE, 2003, 23 (09) :3745-3751
[56]   Number of Aβ inoculations in APP+PS1 transgenic mice influences antibody titers, microglial activation, and congophilic plaque levels [J].
Wilcock, DM ;
Gordon, MN ;
Ugen, KE ;
Gottschall, PE ;
Dicarlo, G ;
Dickey, C ;
Boyett, KW ;
Jantzen, PT ;
Connor, KE ;
Melachrino, J ;
Hardy, J ;
Morgan, D .
DNA AND CELL BIOLOGY, 2001, 20 (11) :731-736
[57]   Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage [J].
Wilcock, Donna M. ;
Rojiani, Amyn ;
Rosenthal, Arnon ;
Subbarao, Sangeetha ;
Freeman, Melissa J. ;
Gordon, Marcia N. ;
Morgan, Dave .
JOURNAL OF NEUROINFLAMMATION, 2004, 1 (1)
[58]   TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice [J].
Wyss-Coray, T ;
Lin, C ;
Yan, FR ;
Yu, GQ ;
Rohde, M ;
McConlogue, L ;
Masliah, E ;
Mucke, L .
NATURE MEDICINE, 2001, 7 (05) :612-618
[59]   Novel Aβ peptide immunogens modulate plaque pathology and inflammation in a murine model of Alzheimer's disease [J].
Zhou, Jun ;
Fonseca, Maria I. ;
Kayed, Rakez ;
Hernandez, Irma ;
Webster, Scott D. ;
Yazan, Ozkan ;
Cribbs, David H. ;
Glabe, Charles G. ;
Tenner, Andrea J. .
JOURNAL OF NEUROINFLAMMATION, 2005, 2 (1)